IMP
Process View
positive regulation of mesonephros development
Any process that increases the rate, frequency or extent of mesonephros development. Mesonephros development is the process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. The mesonephros is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of mesonephros development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.996 | ||
| NRP1 | neuropilin 1 | 0.995 | ||
| PJA1 | praja ring finger 1 | 0.937 | ||
| ENG | endoglin | 0.885 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.838 | ||
| FSTL1 | follistatin-like 1 | 0.760 | ||
| PGF | placental growth factor | 0.617 | ||
| MAGED2 | melanoma antigen family D, 2 | 0.581 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.556 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.550 | ||
| NKX2-1 | NK2 homeobox 1 | 0.270 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.261 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.244 | ||
| THBS1 | thrombospondin 1 | 0.222 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.215 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.123 | ||
| BMP2 | bone morphogenetic protein 2 | 0.115 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.110 | ||
| BMP7 | bone morphogenetic protein 7 | 0.083 | ||
| PAX8 | paired box 8 | 0.062 | Mouse | |
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.060 | ||
| MDFI | MyoD family inhibitor | 0.059 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.051 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.047 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.044 | ||
| DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 | 0.042 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.040 | ||
| DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.034 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.034 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.033 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.033 | ||
| CD2BP2 | CD2 (cytoplasmic tail) binding protein 2 | 0.031 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.030 | ||
| C5orf13 | chromosome 5 open reading frame 13 | 0.030 | ||
| ZNF205 | zinc finger protein 205 | 0.029 | ||
| SMAD7 | SMAD family member 7 | 0.029 | ||
| HOXB6 | homeobox B6 | 0.028 | ||
| PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 0.028 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.028 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.027 | ||
| PAX7 | paired box 7 | 0.027 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.026 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.025 | ||
| HNF1A | HNF1 homeobox A | 0.025 | ||
| WT1 | Wilms tumor 1 | 0.025 | Mouse | |
| BBS4 | Bardet-Biedl syndrome 4 | 0.024 | ||
| HOXB5 | homeobox B5 | 0.024 | ||
| SIM2 | single-minded homolog 2 (Drosophila) | 0.024 | ||
| COPG | coatomer protein complex, subunit gamma | 0.024 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.023 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.023 | ||
| STC1 | stanniocalcin 1 | 0.023 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.022 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.022 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.021 | ||
| HOXA11 | homeobox A11 | 0.021 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.021 | ||
| TAOK1 | TAO kinase 1 | 0.021 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.021 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.020 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.019 | ||
| SSR1 | signal sequence receptor, alpha | 0.018 | ||
| SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 0.017 | ||
| EYA1 | eyes absent homolog 1 (Drosophila) | 0.017 | ||
| FOXA2 | forkhead box A2 | 0.017 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.017 | ||
| AKNA | AT-hook transcription factor | 0.017 | ||
| ATXN10 | ataxin 10 | 0.016 | ||
| PRPF6 | PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae) | 0.016 | ||
| MMP19 | matrix metallopeptidase 19 | 0.016 | ||
| NDNL2 | necdin-like 2 | 0.016 | ||
| PAEP | progestagen-associated endometrial protein | 0.016 | ||
| CEP164 | centrosomal protein 164kDa | 0.016 | ||
| CLU | clusterin | 0.015 | ||
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.015 | ||
| STC2 | stanniocalcin 2 | 0.015 | ||
| PAX2 | paired box 2 | 0.015 | Mouse | |
| INHBB | inhibin, beta B | 0.015 | ||
| ARRB1 | arrestin, beta 1 | 0.015 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.015 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.015 | ||
| EFNA1 | ephrin-A1 | 0.015 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.015 | ||
| VTN | vitronectin | 0.014 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.014 | ||
| ELANE | elastase, neutrophil expressed | 0.014 | ||
| CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.014 | ||
| LDLR | low density lipoprotein receptor | 0.014 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.014 | ||
| GFRA3 | GDNF family receptor alpha 3 | 0.014 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.014 | ||
| PSMF1 | proteasome (prosome, macropain) inhibitor subunit 1 (PI31) | 0.013 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.013 | ||
| NOTCH1 | notch 1 | 0.013 | ||
| LHX1 | LIM homeobox 1 | 0.013 | Mouse | |
| HMGA2 | high mobility group AT-hook 2 | 0.013 | ||
| NKX2-8 | NK2 homeobox 8 | 0.013 | ||
| FST | follistatin | 0.013 | ||
| HNF1B | HNF1 homeobox B | 0.013 | ||
| LBX1 | ladybird homeobox 1 | 0.012 | ||
| GFRA1 | GDNF family receptor alpha 1 | 0.012 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.012 | ||
| NPAS1 | neuronal PAS domain protein 1 | 0.012 | ||
| BTG1 | B-cell translocation gene 1, anti-proliferative | 0.012 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.012 | ||
| EDEM1 | ER degradation enhancer, mannosidase alpha-like 1 | 0.012 | ||
| SHB | Src homology 2 domain containing adaptor protein B | 0.012 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.012 | ||
| SSTR5 | somatostatin receptor 5 | 0.012 | ||
| OVOL1 | ovo-like 1(Drosophila) | 0.012 | ||
| FOXD1 | forkhead box D1 | 0.012 | ||
| LAMC3 | laminin, gamma 3 | 0.012 | ||
| GSDMB | gasdermin B | 0.012 | ||
| FOXF1 | forkhead box F1 | 0.012 | ||
| CALCA | calcitonin-related polypeptide alpha | 0.011 | ||
| ZNF512B | zinc finger protein 512B | 0.011 | ||
| GDNF | glial cell derived neurotrophic factor | 0.011 | ||
| SCG5 | secretogranin V (7B2 protein) | 0.011 | ||
| HOXC6 | homeobox C6 | 0.011 | ||
| FOSL2 | FOS-like antigen 2 | 0.011 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.011 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.011 | ||
| TCF21 | transcription factor 21 | 0.011 | ||
| FGF18 | fibroblast growth factor 18 | 0.011 | ||
| HOXB4 | homeobox B4 | 0.011 | ||
| LMX1B | LIM homeobox transcription factor 1, beta | 0.011 | ||
| IER3 | immediate early response 3 | 0.011 | ||
| LPAR3 | lysophosphatidic acid receptor 3 | 0.011 | ||
| HOXD13 | homeobox D13 | 0.011 | ||
| POU3F1 | POU class 3 homeobox 1 | 0.011 | ||
| FTO | fat mass and obesity associated | 0.011 | ||
| PAX6 | paired box 6 | 0.011 | ||
| SAA2 | serum amyloid A2 | 0.011 | ||
| KIAA0408 | KIAA0408 | 0.011 | ||
| HOXC5 | homeobox C5 | 0.011 | ||
| HOXB3 | homeobox B3 | 0.011 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.011 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.010 | ||
| SHH | sonic hedgehog | 0.010 | ||
| HOXA10 | homeobox A10 | 0.010 | ||
| NKX6-1 | NK6 homeobox 1 | 0.010 | ||
| MAGEH1 | melanoma antigen family H, 1 | 0.010 | ||
| GFRA2 | GDNF family receptor alpha 2 | 0.010 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.010 | ||
| TBX1 | T-box 1 | 0.010 | ||
| ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | 0.010 | ||
| SMAD3 | SMAD family member 3 | 0.010 | ||
| FGF3 | fibroblast growth factor 3 | 0.010 | ||
| TH | tyrosine hydroxylase | 0.010 | ||
| COPG2 | coatomer protein complex, subunit gamma 2 | 0.010 | ||
| SLC30A3 | solute carrier family 30 (zinc transporter), member 3 | 0.010 | ||
| ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | 0.010 | ||
| NPM3 | nucleophosmin/nucleoplasmin 3 | 0.010 | ||
| JAM2 | junctional adhesion molecule 2 | 0.010 | ||
| SIX2 | SIX homeobox 2 | 0.010 | ||
| OTX2 | orthodenticle homeobox 2 | 0.010 | ||
| ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) | 0.010 | ||
| TLX2 | T-cell leukemia homeobox 2 | 0.010 |